KELONA, BC / January 4, 2024 / Lexaria Bioscience Corp
Highlights: Retatrutide targets GLP-1, GIP, and glucagon to reduce appetite, regulate fat storage, and manage blood sugar A trial showed a higher dose of Retatrutide produced 20% more weight loss over 48 weeks Common side effects include diarrhea, nausea, and vomiting , with at least one death reported Trusted Source Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial Go to source)
Here are some tips on how to be successful with each type of medication: Injections: Follow storage instructions on the package
Victoza (liraglutide) is injected once daily
Last but certainly not least, when they are ready to reduce or stop medication, they need a plan that keeps them moving forward, not backward with rebound
Joshua Rocker MD, Cohen Childrens Medical Center, New Hyde Park, NY